long intergenic non-protein coding RNA 390Genealiases: []
Q-omics provides the consensus-scored LINC00390 profile across patient tissues and cancer cell-line models. LINC00390 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, LINC00390 is differentially expressed in 6, with the highest sampling consensus in KICH. Additionally, LINC00390 RNA expression shows 11,543 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, KICH, and THYM as cancer lineages where LINC00390 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00390 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00390 survival associations across molecular data types. LINC00390 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00390 RNA expression–survival associations across cancer types. High LINC00390 expression shows unfavorable associations in STAD, KICH, DLBC, UCEC and MESO, but favorable associations in KIRC. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for LINC00390 RNA expression.
This table summarizes LINC00390 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00390. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00390 shows lower tumor expression in KICH, KIRP, COAD, READ, LIHC and CHOL. The KICH box plot shows higher LINC00390 RNA expression in normal versus tumor tissue (log2 FC = −0.646, t-test p < 0.001).
This table shows molecular features associated with LINC00390 in patient tissues and cancer cell lines. In patient samples, LINC00390 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
